HI
HALO icon

Horizon Investments’s Halozyme HALO Stock Holding History

Horizon Investments’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.02M Buy
13,095
+11,851
+953% +$808K 0.01% 727
2026
Q1 		$80.4K Sell
1,244
-1,664
-57% -$117K ﹤0.01% 1102
2025
Q4 		$196K Sell
2,908
-32,553
-92% -$2.19M ﹤0.01% 956
2025
Q3 		$2.6M Buy
35,461
+6,691
+23% +$444K 0.03% 388
2025
Q2 		$1.5M Buy
+28,770
New +$1.64M 0.02% 463
2024
Q4 		– Sell
-28
Closed -$1.6K – 894
2024
Q3 		$1.6K Buy
+28
New +$1.6K ﹤0.01% 732

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Horizon Investments's HALO Position: Q2 2026 in Review

Horizon Investments increased its Halozyme (HALO) stake by 953% in Q2 2026, buying an estimated $808K and bringing the position to 13,095 shares worth $1.02M. The position accounts for 0.01% of the portfolio, ranked #727.

Horizon Investments first reported a position in HALO in Q3 2024 and has held it in 6 quarters since. The position peaked at $2.6M in Q3 2025. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Horizon Investments held 13,095 shares of Halozyme worth $1.02M as of Q2 2026.
  • Horizon Investments bought 11,851 Halozyme shares in Q2 2026, an estimated $808K.
  • Halozyme made up 0.01% of Horizon Investments's portfolio in Q2 2026, its #727 holding.
  • Horizon Investments first reported a position in Halozyme in Q3 2024 and has held it in 6 quarters since.
  • Horizon Investments's Halozyme position peaked at $2.6M in Q3 2025.
  • 674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Horizon Investments's 13F filing for Q2 2026, filed 13 Aug 2026.